9823 PCF HTS BLVD STE J SAN DIEGO, CA 92121 Get Directions
9823 PCF HTS BLVD STE J SAN DIEGO, CA 92121 Get Directions
Abwiz Bio was founded to leverage the power of state-of-the-art recombinant antibody technologies to develop research tools, diagnostics and co-develop therapeutics. The founding and executive team at Abwiz Bio has extensive experience in the antibody space from discovery and lead identification through commercialization.
Abwiz Bio's Needle-in-a-Haystack(TM) technology combines a differentiating and proprietary antibody library cloning method, WizAmp(TM), novel as well as conventional animal immunization protocols and the robustness of phage display. These together enable the generation of antibodies with affinities typically attained only through hybridoma development, but doing so with the speed and diversity of phage display technology.
The process additionally allows for efficient, high throughput identification of rare binders with distinctive characteristics required for a specific application. Furthermore, the Needle-in-a-Haystack(TM) technology allows Abwiz Bio to generate antibodies to targets that have traditionally been difficult to attain, such as GPCRs.
Abwiz Bio's antibody technology platform coupled with our partner-friendly business terms (no royalties and minimal upfront fees), provide significant advantages to partners in seeking specific antibodies.
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.